The unique properties of the Q Chip BiologiX production system, consistency, continuous operation and inherent quality control, make for an ideal platform for the micro-encapsulation of biologics.
Microspheres can be produced from a large range of bio-resorbable polymers and precisely dosed with biological active material. This technology addresses the key issues of drug microencapsulation including:
- Increased drug loading
- Efficiency and robustness of microsphere production
- Control of particle size and release profile
- Minimising loss of drug activity during the encapsulation process
- Low boiling, chlorinated solvents (chloroform / DCM) are NOT required
The advantages of consistent and controllable particle size distribution are that drug release characteristics are typically more consistent, and there is increased scope for the use of microsphere blending, to achieve optimal delivery profile.
Q Chip is developing an exclusive product pipeline based on its BiologiX technology.